- Home
- ZURA vs BRBI Comparison
ZURA vs BRBI Comparison
Compare ZURA & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZURA | BRBI |
|---|---|---|
| Founded | 2022 | 2009 |
| Country | United States | Brazil |
| Employees | 30 | 188 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.8M | 383.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ZURA | BRBI |
|---|---|---|
| Price | $5.71 | $15.44 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 601.3K | 3.0K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 4.69% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $17.24 |
| P/E Ratio | ★ N/A | $11.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $12.54 |
| 52 Week High | $7.25 | $67.01 |
Technical Indicators
Market Signals| Indicator | ZURA | BRBI |
|---|---|---|
| Relative Strength Index (RSI) | 43.20 | 53.52 |
| Support Level | $5.35 | $13.77 |
| Resistance Level | $5.75 | $15.63 |
| Average True Range (ATR) | 0.34 | 0.29 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 22.12 | 57.14 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About BRBI BRBI BR Partners S.A. ADSs
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.